Product image of Lynparza (Olaparib) supplied by GNH India

Lynparza

Active Ingredient:
Olaparib
Origin:
EU

Lynparza (Olaparib)

Lynparza (Olaparib) is an oral medication used for targeted therapy in certain cancer treatments. This pharmaceutical is designed to inhibit PARP enzymes, supporting personalized cancer care.

Manufacturer / TM Owner

Astrazeneca Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lynparza is primarily used in the treatment of specific types of cancer, particularly those with BRCA mutations. It is often prescribed for ovarian, breast, and prostate cancers, where it helps to target and disrupt cancer cell repair mechanisms. Patients may wonder, 'What is Lynparza used for?' and the answer lies in its role in precision oncology, offering a tailored approach to cancer therapy.

Side Effects

  • Common effects of Lynparza may include fatigue, nausea, and anemia. Some users might experience vomiting or appetite loss. These effects can vary widely among individuals, and it's important to monitor any changes in health while using this medication.

Precautions & Warnings

  • Lynparza should be handled with care, following the guidance of a healthcare provider. It is essential to discuss any pre-existing conditions or other medications being taken to ensure safe usage. Regular monitoring and follow-up appointments are recommended.

Avoid Interactions

  • Lynparza may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid grapefruit products, as they can impact the metabolism of this drug. Always consult a healthcare professional before starting or stopping any medication while using Lynparza.

Frequently Asked Questions

Lynparza is used in the treatment of certain types of cancer, particularly those with BRCA mutations, by targeting and disrupting cancer cell repair mechanisms.

Lynparza is taken orally, and the specific dosage and schedule should be determined by a healthcare provider based on individual needs.

Common side effects may include fatigue, nausea, anemia, vomiting, and appetite loss. These effects can vary among individuals.

Lynparza may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Lynparza is specifically designed for certain types of cancer with BRCA mutations and may not be suitable for all cancer types.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Olaparib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT